Listen: Green Goodbyes: Choosing an Eco-Friendly Burial
Environmental and economic concerns prompt some people to explore obsequies options beyond metal caskets and cremation.
Why Brittle Bones Aren’t Just a Woman’s Problem
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated.
Journalists Dig Into Government Shutdown and Rural Doctor Drought
KFF Health News journalists made the rounds on national media recently to discuss topical stories. Here’s a collection of their appearances.
As Trump Denies Climate Change, At Least 170 Hospitals Face Major Flood Risk
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Senators Press Deloitte, Other Contractors on Errors in Medicaid Eligibility Systems
As contractors position themselves to cash in on a gush of new business managing Medicaid work requirements, a cadre of senators has launched an inquiry into the companies paid billions to build eligibility systems.
Cops on Ketamine? Largely Unregulated Mental Health Treatment Faces Hurdles
Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress — a potential tool for those with high trauma rates, like firefighters and police officers. Yet the drug’s stigma and unregulated marketplace leave first responders in uncharted territory.
Trump Called Digital Equity Act ‘Racist.’ Now Internet Money for Rural Americans Is Gone.
President Donald Trump called the Digital Equity Act unconstitutional, racist, and illegal. Then the $2.75 billion program for rural and underserved communities to gain internet access disappeared.
KFF Health News' 'What the Health?': Starting To Feel the Shutdown’s Bite
The government shutdown continues with no end in sight, and while it theoretically should not affect entitlement programs, the lapse of some related authorizations — like for Medicare telehealth programs — is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill. Sarah Karlin-Smith of Pink Sheet, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews Sarah Grusin of the National Health Law Program.
